Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tyrosine kinase inhibitors (TKIs) for ovarian cancer treatment: from organic to inorganic chemotherapeutics towards selectivity—a perspective overview
Authors
Keywords
-
Journal
BIOMETALS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s10534-023-00547-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inducing a pH-dependent conformational response by competitive binding to Zn2+ of a series of chiral ligands of disparate basicity
- (2022) Matthew M. Wootten et al. Chemical Science
- Platinum-based drugs for cancer therapy and anti-tumor strategies
- (2022) Chunyu Zhang et al. Theranostics
- Metal-Tyrosine Kinase Inhibitors: Targeted metal-drug conjugates
- (2022) Darren F. Beirne et al. COORDINATION CHEMISTRY REVIEWS
- Kinase Inhibitors in the Treatment of Ovarian Cancer: Current State and Future Promises
- (2022) Aikaterini Skorda et al. Cancers
- The Systemic Treatment of Recurrent Ovarian Cancer revisited
- (2021) T. Baert et al. ANNALS OF ONCOLOGY
- Inhibition studies on carbonic anhydrase isoforms I, II, IV and IX with N-arylsubstituted secondary sulfonamides featuring a bicyclic tetrahydroindazole scaffold
- (2021) Silvia Salerno et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells
- (2021) Tiziano Marzo et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Application of a Novel Metallomics Tool to Probe the Fate of Metal-Based Anticancer Drugs in Blood Plasma: potential, challenges and prospects
- (2020) Sophia Sarpong-Kumankomah et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy
- (2020) Miriam Sraieb et al. MEDICINE
- The Effects on Angiogenesis of Relevant Inorganic Chemotherapeutics
- (2020) Tiziano Marzo et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Two novel platinum(II) complexes with sorafenib and regorafenib: Synthesis, structural characterization, and evaluation of in vitro antitumor activity
- (2019) Qi-Pin Qin et al. INORGANIC CHEMISTRY COMMUNICATIONS
- ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†
- (2019) N Colombo et al. ANNALS OF ONCOLOGY
- The cisplatin/serum albumin system: A reappraisal
- (2019) Lara Massai et al. INORGANICA CHIMICA ACTA
- Kinase Inhibitors and Ovarian Cancer
- (2019) Katopodis et al. Cancers
- Classification of Metal-Based Drugs according to Their Mechanisms of Action
- (2019) Eszter Boros et al. Chem
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- PET/CT in Radiation Therapy Planning
- (2018) Lena Specht et al. SEMINARS IN NUCLEAR MEDICINE
- An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment
- (2018) Takeshi Motohara et al. ONCOGENE
- Anti-angiogenic agents in ovarian cancer: past, present, and future
- (2016) B. J. Monk et al. ANNALS OF ONCOLOGY
- Functional role of inorganic trace elements in angiogenesis—Part I: N, Fe, Se, P, Au, and Ca
- (2015) Mohammad Ali Saghiri et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- An overview of tyrosine kinase inhibitors for the treatment of epithelial ovarian cancer
- (2015) Zhijie Wang et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Interactions of carboplatin and oxaliplatin with proteins: Insights from X-ray structures and mass spectrometry studies of their ribonuclease A adducts
- (2015) Luigi Messori et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Gold(III) complexes with hydroxyquinoline, aminoquinoline and quinoline ligands: Synthesis, cytotoxicity, DNA and protein binding studies
- (2015) Cecilia Martín-Santos et al. JOURNAL OF INORGANIC BIOCHEMISTRY
- Inorganic nanocarriers for platinum drug delivery
- (2015) Ping’an Ma et al. Materials Today
- Novel Action and Mechanism of Auranofin in Inhibition of Vascular Endothelial Growth Factor Receptor-3-Dependent Lymphangiogenesis
- (2014) Xiaodong Chen et al. Anti-Cancer Agents in Medicinal Chemistry
- The X-ray structure of the complex formed in the reaction between oxaliplatin and lysozyme
- (2014) Luigi Messori et al. CHEMICAL COMMUNICATIONS
- Anti-angiogenic effect of auranofin on HUVECs in vitro and zebrafish in vivo
- (2014) Ming-Fang He et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Interactions between Anticancer trans-Platinum Compounds and Proteins: Crystal Structures and ESI-MS Spectra of Two Protein Adducts of trans-(Dimethylamino)(methylamino)dichloridoplatinum(II)
- (2014) Luigi Messori et al. INORGANIC CHEMISTRY
- Fe–salphen complexes from intracellular pH-triggered degradation of Fe3O4@Salphen-InIII CPPs for selectively killing cancer cells
- (2013) Shuai Xu et al. BIOMATERIALS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started